Top Markets
Coin of the day
GlycoNex Incorporation GlycoNex Incorporation

GlycoNex Incorporation

4168
Ранг среди акций #22943
GlycoNex Incorporation, based in New Taipei City, Taiwan, specializes in... GlycoNex Incorporation, based in New Taipei City, Taiwan, specializes in developing innovative cancer therapeutics. The company achieves this by leveraging advanced glycosphingolipid antigen and human monoclonal antibody technologies. Its robust pipeline for solid tumors features several investigational antibody drugs. These include GNX102, a humanized monoclonal antibody currently in Phase 1 clinical trials; GNX201, an antibody candidate undergoing lead optimization; and GNX202, which is in preclinical development. Additionally, GNX203 and GNX204 are antibody drugs presently in the target validation stage. Beyond oncology, GlycoNex is also advancing other therapeutic agents. This includes SPD (Denosumab), a humanized IgG2 antibody in preclinical stages for both osteoporosis and oncology indications. Another key asset is SEA (Aflibercept), a vascular endothelial growth factor (VEGF) binding fusion protein, currently undergoing lead optimization for its potential use in ophthalmology and oncology. GlycoNex was established in 2001.
Цена акции
$0.71865803
Последняя синхронизация: 2026-08-21
Рыночная капитализация
$80.86M
Изменение (1 день)
0.00%
Изменение (1 год)
-5.48%
Страна
TW
Торговля GlycoNex Incorporation (4168)

Категория

История цены акций GlycoNex Incorporation (4168)
Наивысшая цена закрытия: $0.72 2026-08-01

Наименьшая цена закрытия: $2.55 2012-06-01
История цены акций GlycoNex Incorporation с 2012 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) 4.61%
2025 -1.85%
2024 -14.27%
2023 -16.58%
2022 0.65%
2021 19.55%
2020 36.23%
2019 -14.54%
2018 0.91%
2017 -26.75%
2016 -41.27%
2015 -21.61%
2014 -32.30%
2013 -27.14%
2012 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH